SFM
RGLS

Sphera Funds Management’s Regulus Therapeutics RGLS Stock Holding History

Sphera Funds Management’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-452,845
Closed -$792K – 129
2025
Q1 		$792K Buy
+452,845
New +$598K 0.18% 97

Other funds holding RGLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sphera Funds Management's RGLS Position: Q2 2025 in Review

Sphera Funds Management sold out of Regulus Therapeutics (RGLS) in Q2 2025, closing a stake of 452,845 shares — an estimated $792K sold.

Sphera Funds Management first reported a position in RGLS in Q1 2025 and held it in 1 quarter. The position peaked at $792K in Q1 2025. 0 funds tracked by Wall St. Rank hold RGLS as of Q2 2025.

  • Sphera Funds Management reported no remaining Regulus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Sphera Funds Management sold 452,845 Regulus Therapeutics shares in Q2 2025, an estimated $792K.
  • Sphera Funds Management first reported a position in Regulus Therapeutics in Q1 2025 and held it in 1 quarter.
  • Sphera Funds Management's Regulus Therapeutics position peaked at $792K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2025.

Based on Sphera Funds Management's 13F filing for Q2 2025, filed 14 Aug 2025.